AZN compared with BLDR: revenue, margins and what each company keeps, and the suppliers and customers both name

AZNAstrazeneca PLC

Mkt capRevenueRevenue

BLDRBuilders FirstSource, Inc.

Mkt capRevenueRevenue

Compare

AZNAstrazeneca PLC

BLDRBuilders FirstSource, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

AZN: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AZN 20

ARQTArcutis Biotherapeuticscustomer

GRALGrailsupplier

RCUSArcus Biosciencescustomer

NKTRNektar Therapeuticssupplier

16 more · AZN chain ›

Shared 0

No disclosed counterparties: BLDR.

Only BLDR 0

None

Role chip = supplier or customerSource: SEC EDGAR

Price

rebased to 0%

AZN, solidBLDR, dashed

AZNAstrazeneca PLC

186.63▲+7.01%· post 186.35

Mkt cap$289.5BRevenue—Revenue—

BLDRBuilders FirstSource, Inc.

64.54▲+2.34%· post 64.80

ClosedOct 30 '26

Mkt cap$7.0BRevenue$3.9BQ3 FY26Revenue$15.2BFY25

Compare

ClosedOct 30 '26

AZNAstrazeneca PLC

BLDRBuilders FirstSource, Inc.

186.63▲+7.01%post 186.35

Price

64.54▲+2.34%post 64.80

$289.5B

Mkt cap

$7.0B

—

Revenue

$3.9BQ3 FY26

—

Revenue

$15.2BFY25

AZN186.63▲+7.01%vsBLDR64.54▲+2.34%ClosedOct 30 '26